Down-Regulation of Inwardly Rectifying Kir2.1 K+ Channels by Human Parvovirus B19 Capsid Protein VP1

Journal of Membrane Biology

Volumn 248, Issue 2, 2015, Pages 223-229

  Ahmed, Musaab ^a   Elvira, Bernat ^a   Almilaji, Ahmad ^a   Bock, C Thomas ^a   Kandolf, Reinhard ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

ATPase; Channels; Parvovirus B19; Phospholipase A2; Xenopus

Indexed keywords

CAPSID PROTEIN; CAPSID PROTEIN VP1, PARVOVIRUS B19; INWARDLY RECTIFYING POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1;

ANIMAL; DOWN REGULATION; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; HUMAN; MEMBRANE POTENTIAL; METABOLISM; OOCYTE; XENOPUS;

ANIMALS; CAPSID PROTEINS; DOWN-REGULATION; GENE EXPRESSION; HUMANS; MEMBRANE POTENTIALS; OOCYTES; POTASSIUM CHANNELS, INWARDLY RECTIFYING; TRANSFECTION; XENOPUS;

EID: 84939940077     PISSN: 00222631     EISSN: 14321424     Source Type: Journal    
DOI: 10.1007/s00232-014-9762-9     Document Type: Article

References (68)

1. Ahmed M, Almilaji A, Munoz C, Elvira B, Shumilina E, Bock CT, Kandolf R, Lang F (2014) Down-regulation of K(+) channels by human parvovirus B19 capsid protein VP1. Biochem Biophys Res Commun 450:1396–1401
2. Alesutan I, Sopjani M, Dermaku-Sopjani M, Munoz C, Voelkl J, Lang F (2012) Upregulation of Na-coupled glucose transporter SGLT1 by Tau tubulin kinase 2. Cell Physiol Biochem 30:458–465
3. −-coupled betaine/γ-amino-butyric acid transporter BGT1 by Tau tubulin kinase 2. Cell Physiol Biochem 32:334–343
4. + ATPase activity by human parvovirus B19 capsid protein VP1. Cell Physiol Biochem 31:638–648
5. Anderson MJ, Jones SE, Fisher-Hoch SP, Lewis E, Hall SM, Bartlett CL, Cohen BJ, Mortimer PP, Pereira MS (1983) Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet 1:1378
6. Bock CT, Klingel K, Kandolf R (2010) Human parvovirus B19-associated myocarditis. N Engl J Med 362:1248–1249
7. Bogatikov E, Munoz C, Pakladok T, Alesutan I, Shojaiefard M, Seebohm G, Foller M, Palmada M, Bohmer C, Broer S, Lang F (2012) Up-regulation of amino acid transporter SLC6A19 activity and surface protein abundance by PKB/Akt and PIKfyve. Cell Physiol Biochem 30:1538–1546
8. Brown KE (1989) What threat is human parvovirus B19 to the fetus? A review. Br J Obstet Gynaecol 96:764–767
9. Brown KE, Anderson SM, Young NS (1993) Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262:114–117
10. Brown KE, Hibbs JR, Gallinella G, Anderson SM, Lehman ED, McCarthy P, Young NS (1994a) Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med 330:1192–1196
11. Brown KE, Young NS, Liu JM (1994b) Molecular, cellular and clinical aspects of parvovirus B19 infection. Crit Rev Oncol Hematol 16:1–31
12. Bultmann BD, Klingel K, Sotlar K, Bock CT, Baba HA, Sauter M, Kandolf R (2003) Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. Hum Pathol 34:92–95
13. Canaan S, Zadori Z, Ghomashchi F, Bollinger J, Sadilek M, Moreau ME, Tijssen P, Gelb MH (2004) Interfacial enzymology of parvovirus phospholipases A2. J Biol Chem 279:14502–14508
14. Corman LC, Dolson DJ (1992) Polyarteritis nodosa and parvovirus B19 infection. Lancet 339:491
15. Cotmore SF, McKie VC, Anderson LJ, Astell CR, Tattersall P (1986) Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments. J Virol 60:548–557
16. Crane J (2002) Parvovirus B19 infection in pregnancy. J Obstet Gynaecol Can 24:727–743
17. Dingli D, Pfizenmaier DH, Arromdee E, Wennberg P, Spittell PC, Chang-Miller A, Clarke BL (2000) Severe digital arterial occlusive disease and acute parvovirus B19 infection. Lancet 356:312–314
18. Doerig C, Beard P, Hirt B (1987) A transcriptional promoter of the human parvovirus B19 active in vitro and in vivo. Virology 157:539–542
19. Dorsch S, Liebisch G, Kaufmann B, von Landenberg P, Hoffmann JH, Drobnik W, Modrow S (2002) The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. J Virol 76:2014–2018
20. Drago F, Semino M, Rampini P, Rebora A (1999) Parvovirus B19 infection associated with acute hepatitis and a purpuric exanthem. Br J Dermatol 141:160–161
21. Duechting A, Tschope C, Kaiser H, Lamkemeyer T, Tanaka N, Aberle S, Lang F, Torresi J, Kandolf R, Bock CT (2008) Human parvovirus B19 NS1 protein modulates inflammatory signaling by activation of STAT3/PIAS3 in human endothelial cells. J Virol 82:7942–7952
22. Ellis PD, Metcalfe JC, Hyvonen M, Kemp PR (2003) Adhesion of endothelial cells to NOV is mediated by the integrins alphavbeta3 and alpha5beta1. J Vasc Res 40:234–243
23. Finkel TH, Torok TJ, Ferguson PJ, Durigon EL, Zaki SR, Leung DY, Harbeck RJ, Gelfand EW, Saulsbury FT, Hollister JR (1994) Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet 343:1255–1258
24. Gigler A, Dorsch S, Hemauer A, Williams C, Kim S, Young NS, Zolla-Pazner S, Wolf H, Gorny MK, Modrow S (1999) Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins. J Virol 73:1974–1979
25. Heegaard ED, Brown KE (2002) Human parvovirus B19. Clin Microbiol Rev 15:485–505
26. Henrion U, Zumhagen S, Steinke K, Strutz-Seebohm N, Stallmeyer B, Lang F, Schulze-Bahr E, Seebohm G (2012) Overlapping cardiac phenotype associated with a familial mutation in the voltage sensor of the KCNQ1 channel. Cell Physiol Biochem 29:809–818
27. Hillingso JG, Jensen IP, Tom-Petersen L (1998) Parvovirus B19 and acute hepatitis in adults. Lancet 351:955–956
28. Hosseinzadeh Z, Bhavsar SK, Lang F (2012a) Down-regulation of the myoinositol transporter SMIT by JAK2. Cell Physiol Biochem 30:1473–1480
29. Hosseinzadeh Z, Bhavsar SK, Lang F (2012b) Downregulation of ClC-2 by JAK2. Cell Physiol Biochem 29:737–742
30. Hosseinzadeh Z, Dong L, Bhavsar SK, Warsi J, Almilaji A, Lang F (2013) Upregulation of peptide transporters PEPT1 and PEPT2 by Janus kinase JAK2. Cell Physiol Biochem 31:673–682
31. + channel ENaC by Janus kinase 2. J Membr Biol 247:331–338
32. Hsu TC, Wu WJ, Chen MC, Tsay GJ (2004) Human parvovirus B19 non-structural protein (NS1) induces apoptosis through mitochondria cell death pathway in COS-7 cells. Scand J Infect Dis 36:570–577
33. Karetnyi YV, Beck PR, Markin RS, Langnas AN, Naides SJ (1999) Human parvovirus B19 infection in acute fulminant liver failure. Arch Virol 144:1713–1724
34. Katz VL, Chescheir NC, Bethea M (1990) Hydrops fetalis from B19 parvovirus infection. J Perinatol 10:366–368
35. Klingel K, Sauter M, Bock CT, Szalay G, Schnorr JJ, Kandolf R (2004) Molecular pathology of inflammatory cardiomyopathy. Med Microbiol Immunol 193:101–107
36. Koch WC (2001) Fifth (human parvovirus) and sixth (herpesvirus 6) diseases. Curr Opin Infect Dis 14:343–356
37. Kuhl U, Pauschinger M, Bock T, Klingel K, Schwimmbeck CP, Seeberg B, Krautwurm L, Poller W, Schultheiss HP, Kandolf R (2003) Parvovirus B19 infection mimicking acute myocardial infarction. Circulation 108:945–950
38. Lang F (2007) Mechanisms and significance of cell volume regulation. J Am Coll Nutr 26:613S–623S
39. Lang F, Rehwald W (1992) Potassium channels in renal epithelial transport regulation. Physiol Rev 72:1–32
40. Lang F, Busch GL, Ritter M, Volkl H, Waldegger S, Gulbins E, Haussinger D (1998) Functional significance of cell volume regulatory mechanisms. Physiol Rev 78:247–306
41. Lehmann HW, Knoll A, Kuster RM, Modrow S (2003) Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood. Arthritis Rheum 48:1631–1638
42. Li Y, Zadori Z, Bando H, Dubuc R, Fediere G, Szelei J, Tijssen P (2001) Genome organization of the densovirus from Bombyx mori (BmDNV-1) and enzyme activity of its capsid. J Gen Virol 82:2821–2825
43. 2+ entry by human parvovirus B19 capsid protein VP1. J Virol 80:11370–11380
44. Malm C, Fridell E, Jansson K (1993) Heart failure after parvovirus B19 infection. Lancet 341:1408–1409
45. Mia S, Munoz C, Pakladok T, Siraskar G, Voelkl J, Alesutan I, Lang F (2012) Downregulation of Kv1.5 K channels by the AMP-activated protein kinase. Cell Physiol Biochem 30:1039–1050
46. Mitchell LA (2002) Parvovirus B19 nonstructural (NS1) protein as a transactivator of interleukin-6 synthesis: common pathway in inflammatory sequelae of human parvovirus infections? J Med Virol 67:267–274
47. Moffatt S, Yaegashi N, Tada K, Tanaka N, Sugamura K (1998) Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells. J Virol 72:3018–3028
48. Munakata Y, Saito-Ito T, Kumura-Ishii K, Huang J, Kodera T, Ishii T, Hirabayashi Y, Koyanagi Y, Sasaki T (2005) Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection. Blood 106:3449–3456
49. + channel Kir2.1 (KCNJ2) by protein kinase B (PKB/Akt) and PIKfyve. J Membr Biol 246:189–197
50. Munoz C, Pakladok T, Almilaji A, Elvira B, Decher N, Shumilina E, Lang F (2014) Up-regulation of Kir2.1 (KCNJ2) by the serum and glucocorticoid inducible SGK3. Cell Physiol Biochem 33:491–500
51. Nilius B, Droogmans G (2001) Ion channels and their functional role in vascular endothelium. Physiol Rev 81:1415–1459
52. Oyer CE, Ongcapin EH, Ni J, Bowles NE, Towbin JA (2000) Fatal intrauterine adenoviral endomyocarditis with aortic and pulmonary valve stenosis: diagnosis by polymerase chain reaction. Hum Pathol 31:1433–1435
53. +-coupled phosphate cotransporters NaPi-IIa and NaPi-IIb by B-RAF. J Membr Biol 247:137–145
54. Pathare G, Foller M, Daryadel A, Mutig K, Bogatikov E, Fajol A, Almilaji A, Michael D, Stange G, Voelkl J, Wagner CA, Bachmann S, Lang F (2012) OSR1-sensitive renal tubular phosphate reabsorption. Kidney Blood Press Res 36:149–161
55. Pattison JR (1988) Diseases caused by the human parvovirus B19. Arch Dis Child 63:1426–1427
56. +-adenosine triphosphatase. J Clin Endocrinol Metab 83:2405–2410
57. Schowengerdt KO, Ni J, Denfield SW, Gajarski RJ, Bowles NE, Rosenthal G, Kearney DL, Price JK, Rogers BB, Schauer GM, Chinnock RE, Towbin JA (1997) Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction. Circulation 96:3549–3554
58. Shojaiefard M, Hosseinzadeh Z, Bhavsar SK, Lang F (2012) Downregulation of the creatine transporter SLC6A8 by JAK2. J Membr Biol 245:157–163
59. Sokal EM, Melchior M, Cornu C, Vandenbroucke AT, Buts JP, Cohen BJ, Burtonboy G (1998) Acute parvovirus B19 infection associated with fulminant hepatitis of favourable prognosis in young children. Lancet 352:1739–1741
60. Sol N, Le Junter J, Vassias I, Freyssinier JM, Thomas A, Prigent AF, Rudkin BB, Fichelson S, Morinet F (1999) Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19. J Virol 73:8762–8770
61. Telerman A, Tuynder M, Dupressoir T, Robaye B, Sigaux F, Shaulian E, Oren M, Rommelaere J, Amson R (1993) A model for tumor suppression using H-1 parvovirus. Proc Natl Acad Sci USA 90:8702–8706
62. Trapani S, Ermini M, Falcini F (1999) Human parvovirus B19 infection: its relationship with systemic lupus erythematosus. Semin Arthritis Rheum 28:319–325
63. Tschope C, Bock CT, Kasner M, Noutsias M, Westermann D, Schwimmbeck PL, Pauschinger M, Poller WC, Kuhl U, Kandolf R, Schultheiss HP (2005) High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation 111:879–886
64. Warsi J, Elvira B, Hosseinzadeh Z, Shumilina E, Lang F (2014) Downregulation of chloride channel ClC-2 by Janus kinase 3. J Membr Biol 247:387–393
65. Weigel-Kelley KA, Yoder MC, Srivastava A (2003) Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry. Blood 102:3927–3933
66. Yoto Y, Kudoh T, Haseyama K, Suzuki N, Chiba S (1996) Human parvovirus B19 infection associated with acute hepatitis. Lancet 347:868–869
67. Young NS, Brown KE (2004) Parvovirus B19. N Engl J Med 350:586–597
68. Zadori Z, Szelei J, Lacoste MC, Li Y, Gariepy S, Raymond P, Allaire M, Nabi IR, Tijssen P (2001) A viral phospholipase A2 is required for parvovirus infectivity. Dev Cell 1:291–302